Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONE
826
DELISTED
CyrusOne Inc Common Stock
CONE
| $16.9M | 0.01% |
188,214
+46,152
| +32% | +$3.92M |
|
827
Paychex
PAYX
$43.4B
| $16.9M | 0.01% |
123,451
-205,351
| -62% | -$25.4M |
|
828
Caribou Biosciences
CRBU
$146M
| $16.7M | 0.01% |
1,172,725
-66,927
| -5% | -$1.3M |
|
829
Lockheed Martin
LMT
$131B
| $16.7M | 0.01% |
47,058
-387,169
| -89% | -$134M |
|
|
DAWN
830
DELISTED
Day One Biopharmaceuticals
DAWN
| $16.6M | 0.01% |
1,022,548
+65
| +0% | +$1.34K |
|
831
Carlyle Group
CG
$16.1B
| $16.3M | 0.01% |
296,884
+154,529
| +109% | +$8.42M |
|
832
Clear Secure
YOU
$5.88B
| $16.3M | 0.01% |
519,579
-80,457
| -13% | -$2.97M |
|
833
Prudential Financial
PRU
$42.6B
| $16M | 0.01% |
147,958
-280,399
| -65% | -$30.5M |
|
834
Tyra Biosciences
TYRA
$1.85B
| $15.9M | 0.01% |
1,166,481
-208,167
| -15% | -$4.14M |
|
|
RAIN
835
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $15.8M | 0.01% |
1,230,455
-171,619
| -12% | -$2.45M |
|
836
Axogen
AXGN
$2.2B
| $15.8M | 0.01% |
1,686,156
+380,780
| +29% | +$4.57M |
|
837
Beyond Meat
BYND
$274M
| $15.6M | 0.01% |
239,467
+84,051
| +54% | +$7.15M |
|
838
Pyxis Oncology
PYXS
$185M
| $15.3M | 0.01% |
+1,469,091
| New | +$16.8M |
|
839
Idexx Laboratories
IDXX
$44.9B
| $15.1M | 0.01% |
22,921
-11,739
| -34% | -$7.37M |
|
840
Truist Financial
TFC
$63.9B
| $15M | 0.01% |
256,831
-4,673
| -2% | -$285K |
|
841
Advantage Solutions
ADV
$575M
| $14.9M | 0.01% |
74,501
+187
| +0.3% | +$38.4K |
|
842
Manchester United
MANU
$4.03B
| $14.9M | 0.01% |
1,046,840
| – | – |
|
|
AUY
843
DELISTED
Yamana Gold, Inc.
AUY
| $14.9M | 0.01% |
3,538,029
+1,776,348
| +101% | +$7.36M |
|
844
US Bancorp
USB
$97.9B
| $14.9M | 0.01% |
264,827
-88,113
| -25% | -$5.21M |
|
845
Burford Capital
BUR
$914M
| $14.9M | 0.01% |
1,424,004
+19,257
| +1% | +$205K |
|
|
CWAN
846
DELISTED
Clearwater Analytics
CWAN
| $14.8M | 0.01% |
645,519
-20,296
| -3% | -$459K |
|
847
Altria Group
MO
$125B
| $14.8M | 0.01% |
311,874
-25,712
| -8% | -$1.18M |
|
848
United Therapeutics
UTHR
$26.1B
| $14.8M | 0.01% |
68,313
+60,658
| +792% | +$11.9M |
|
849
AST SpaceMobile
ASTS
$15.8B
| $14.6M | 0.01% |
1,832,770
+9
| +0% | +$92 |
|
|
ACC
850
DELISTED
American Campus Communities, Inc.
ACC
| $14.6M | 0.01% |
253,956
+62,621
| +33% | +$3.34M |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.